Patent · US Active

Cells expressing a modified T cell receptor

US8361794B2 · kind B2 · utility

16Cited by

1References

25Claims

0Family size

Assignee

IMMUNOCORE LIMITED · GB

Inventor

Bent Karsten Jakobsen · Abingdon, GB

Key dates

Filing date	Jun 29, 2005
Grant date	Jan 29, 2013
Priority date	—
Expiry date	Feb 20, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2510/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides a cell presenting at least one T cell receptor (TCR) anchored to the membrane by a transmembrane sequence, said TCR comprising an interchain disulfide bond between extracellular constant domain residues which is not present in native TCRs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.